Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

Telaprevir and Boceprevir are the first direct acting antivirals approved for chronic hepatitis C in combination with peg-interferon alfa and ribavirin. Pancytopenia due to myelotoxicity caused by these drugs may occur, but severe hematological abnormalities or aplastic anemia (AA) have not been des...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Gastroenterol
Päätekijät: Lens, Sabela, Calleja, Jose L, Campillo, Ana, Carrión, Jose A, Broquetas, Teresa, Perello, Christie, de la Revilla, Juan, Mariño, Zoe, Londoño, María-Carlota, Sánchez-Tapias, Jose M, Urbano-Ispizua, Álvaro, Forns, Xavier
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Inc 2015
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419084/
https://ncbi.nlm.nih.gov/pubmed/25954117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i17.5421
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia